New York Pharma Forum elects new president
This article was originally published in Scrip
Executive Summary
The New York Pharma Forum, a US association of biopharmaceutical companies with a focus on Japan, has elected Dr Sapan Shah as president, effective immediately. Dr Shah, who is president and CEO of Shionogi's US subsidiary and was formerly vice-president of the forum, succeeds Dr Kenji Arima of Asubio Pharmaceuticals in the US, who is returning to Japan. The non-profit group organises networking and educational events on various issues for industry and other members and was set up around 20 years ago.
You may also be interested in...
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Galderma prepares to take on Dupixent; Pfizer’s plans for Adcetris in DLBCL; Lilly’s donanemab approval delayed again; the psychedelic R&D pipeline; and an interview with BMS’s CDTO Greg Meyers.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Bayer won’t split, for now; Pfizer’s next-gen ADC pipeline; oncology dominates investment but other areas grow; goodbye NASH, hello MASH; and BMS’s CEO gives his views on India.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: optimistic outlook for biopharma IPOs; Boehringer’s promising MASH results; Viking emerges as obesity contender; Incyte looks to portfolio diversification; and a look at China’s HPV vaccine market.